Response to Comment on Incidence and Risk Factors of Bleeding-Related Adverse Events in Patients with Chronic Lymphocytic Leukemia Treated with Ibrutinib - Andrew H. Lipsky; Jay N. Lozier; Adrian Wiestner (Haematologica, 2016)